Health

Snorles GenioFlex: The Innovative Daytime Solution for Snoring Management Now Launched on Indiegogo

HONG KONG, July 10, 2024 /PRNewswire/ -- Snorles, a leading innovator in sleep technology, is excited to announce the launch of its latest product, GenioFlex. Snorles created to address snoring issues and promote overall health and well-being, GenioFlex offers a fresh approach to managing snoring...

2024-07-10 20:02 1695

AIRS Medical Secures $20M in Series C Funding to Advance AI-Powered Preventive Healthcare Solutions

SEOUL, South Korea, July 10, 2024 /PRNewswire/ -- AIRS Medical, a pioneering force in artificial intelligence (AI) and robotics for healthcare applications, today announced the completion of its Series C funding round, securing$20 million from seven institutional investors in Korea. The investmen...

2024-07-10 18:45 3866

Hi-MO X6 Lights Up Thai Hospital, Bringing Sustainable Power to Healthcare

BANGKOK, July 10, 2024 /PRNewswire/ -- Stable power supply is essential for the continuous operation of health care facilities. With Hi-MO X6 solar panels, Phraphrom Hospital has become a great example of sustainable healthcare. Phraphrom H...

2024-07-10 15:32 1848

8TV "JASMINE PROJECT LOVE" PROVIDES HELPING HAND TO THOSE IN NEED

Season 2 Expected to Begin Filming by Year-End PETALING JAYA, Malaysia, July 10, 2024 /PRNewswire/ -- Since its premiere, 8TV's 20th-anniversary special programme, "Jasmine Project Love", has received overwhelming support from various sectors and touched the lives of many in Malaysia. "Jasmine Pr...

2024-07-10 14:18 1779

WuXi Biologics Named Constituent of the FTSE4Good Index Series for Fourth Year

SHANGHAI, July 10, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has again been named as a constituent company of the FTSE4Good Index Series. This marks the fourth consecutive year t...

2024-07-10 13:30 3387

3D Artificial Cornea from Stem Cells: Chula Researchers Advance Canine Corneal Wound Treatment

BANGKOK, July 10, 2024 /PRNewswire/ -- Chulalongkorn University's Faculty of Veterinary Science and the Faculty of Engineering have worked together to research and develop a three-dimensional artificial cornea from stem cells that offers a way to treat deep corneal wounds in dogs. The innovation ...

2024-07-10 09:00 2511

USANA Ranked #1 Direct Selling Brand for Calcium Supplements in Hong Kong

Euromonitor International honors USANA Hong Kong for second consecutive year HONG KONG, July 10, 2024 /PRNewswire/ -- USANA Hong Kong was recently recognized as a top brand for calcium supplements by market research giant Euromonitor International. This distinction is based on market research of ...

2024-07-10 07:49 1820

KOSÉ, I Peace, and Reju Enter Strategic Partnership to Develop Personalized Beauty Products Based on iPS Cells

Demonstration testing of "my own" beauty products PALO ALTO, Calif., July 9, 2024 /PRNewswire/ -- KOSÉ Corporation (Headquarters: Chuo-ku,Tokyo; President: Kazutoshi Kobayashi), I Peace, Inc. (Headquarters:Palo Alto, California, USA; Founder & CEO: Koji Tanabe), and Reju, Inc. (Headquarters: Min...

2024-07-09 23:00 2026

Bestqool Pro Series Redefines the Standard of Red Light Therapy Devices: Cutting-Edge Technology Undergone the Third-party Laboratory Diagnostic Testing

NEW YORK, July 9, 2024 /PRNewswire/ -- Bestqool, as one of the industry's top makers of innovative red light therapy devices for over six years, in recent months proactively sent their Pro Series devices to LightLab International Allentown LLC, a reputable third-party laboratory in the US. Bestqo...

2024-07-09 21:00 2189

Clinion Applauded by Frost & Sullivan for Enabling Interoperability and Continuity in Clinical Trials Management with its eClinical Solutions

Clinion's decentralized clinical trials and innovative eClinical platform enhance accessibility, cost efficiency, ease of use, regulatory compliance, and sustainability in clinical development. SAN ANTONIO, July 9, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the integrated clinical t...

2024-07-09 21:00 1925

Pulnovo Medical Announces Joining PHA's (Pulmonary Hypertension Association) Corporate Committee

SHANGHAI, July 9, 2024 /PRNewswire/ -- Pulnovo Medical, a globally recognized device pioneer in the treatment for pulmonary hypertension and heart failure, has recently announced its partnership with the Pulmonary Hypertension Association (PHA). This partnership not only underscores Pulnovo Medic...

2024-07-09 20:00 1943

Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development

CHONGQING, China, July 8, 2024 /PRNewswire/ -- Porton J-STAR today announced that Enabling Technologies Consortium (ETC) has awarded a two-year contract to J-STAR to collaborate on "Co-processing Platform Technology." The primary goal of co-p...

2024-07-08 22:00 1485

Goodix Launches Its Latest Automotive-Grade Bluetooth LE SoC and CGM Solutions at electronica China 2024

SHENZHEN, China, July 8, 2024 /PRNewswire/ -- Goodix Technology today unveiled its Continuous Glucose Monitoring (CGM) solutions and automotive-grade Bluetooth LE SoC at the electronicaChina 2024. Demonstrating a dedication to innovation in sensing and wireless technology, Goodix showcased its la...

2024-07-08 22:00 2191

Alteogen Receives Ministry of Food and Drug Safety (MFDS) Approval for Tergase®

* Tergase® poised to capture a fair share of the global hyaluronidase market. DAEJEON, South Korea, July 8, 2024 /PRNewswire/ -- Alteogen Inc.  (KOSDAQ:196170) announced that the Ministry of Food and Drug Safety (MFDS) of Korea approved its New Drug Application (NDA...

2024-07-08 21:00 2009

GEN Z TAKING PROACTIVE STEPS TO ADDRESS MENTAL HEALTH ISSUES

Yet youth body confidence, ADHD and general lack of purpose abound according to new research SYDNEY, July 8, 2024 /PRNewswire/ -- More than half of Gen Zs are increasingly seeking out mental health therapy indicating support is needed for an entire generation of Australians plagued by anxiety an...

2024-07-08 19:41 11096

Cambrex to Expand Stability Storage Business with New Facility in Durham, North Carolina

EAST RUTHERFORD, N.J., July 8, 2024 /PRNewswire/ -- Cambrex today announced the expansion of its stability storage business, Q1 Scientific, which offers environmentally-controlled stability storage services to the pharmaceutical, medical device, and life sciences industries. Q1 Scientific will op...

2024-07-08 18:00 1781

DP Technology Announces Nomination of Development Candidate, a CNS Penetrable Lp-PLA2 Inhibitor for Alzheimer's Disease

BEIJING, July 8, 2024 /PRNewswire/ -- DP Technology, an "AI for Science" paradigm-driven company, today announced the nomination of DPT0416, a novel CNS penetrable small molecule targeting Lp-PLA2, as a preclinical candidate for the treatment of Alzheimer's disease (AD). AD is the most frequent ...

2024-07-08 17:23 1415

MGI Tech Partners with Australian Research Council Training Centre CEAStAR to Lead Innovation in Antimicrobial Resistance Solutions

BRISBANE, Australia, July 8, 2024 /PRNewswire/ -- MGI Australia Pty Ltd, subsidiary of MGI Tech Co., Ltd., a company committed to building core tools and technologies that drive innovation in life science, proudly announces its strategic partnership with TheUniversity of Queensland(UQ) led Centre...

2024-07-08 17:14 2369

DP Technology Announces Nomination of Development Candidate, a Potential Best-in-Class Lp-PLA2 Inhibitor for DR and DME

* The nomination of novel Lp-PLA2 inhibitor DPT0415 for the treatment of DR & DME. * DPT0415 is a highly potent, selective and safe Lp-PLA2 inhibitor with sufficient target engagement at a dose of 0.3 mpk and robust efficacy in the STZ-induced rat DR model. * This project further validates ...

2024-07-08 17:00 1439

Immorna Biotherapeutics Receives U.S. FDA IND Clearance to Conduct Phase 1/2 Study of JCXH-211 IV as Monotherapy and in Combination with Checkpoint Inhibitor in Patients with Advanced Solid Tumors

MORRISVILLE, NC., July 8, 2024 /PRNewswire/ -- Immorna Biotherapeutics, Inc. (Immorna), a clinical stage biotechnology company developing both self-replicating and conventional mRNA-based therapeutics and vaccines, announced today that the U.S. Food and Drug Administration (FDA) has cleared its ...

2024-07-08 16:28 1468
1 ... 59606162636465 ... 858